GlassScriptPhysician profile
Jason Daniel Klein
NPI 1902027337
$14,913.02
in general payments reported to CMS, 2019-2025
55 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,843 · 2020: $1,788 · 2021: $2,777 · 2022: $2,028 · 2023: $1,897 · 2024: $2,016 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,477.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,809.84 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Ranger |
| Novartis Pharmaceuticals Corporation | $1,239.69 | 2019-2025 | |
| Amgen INC. | $1,224.16 | 2019-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $1,027.43 | 2021-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,000.24 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $858.71 | 2019-2024 | Xarelto |
| Biotronik INC. | $539.98 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $522.32 | 2019-2025 | Farxiga |
| Edwards Lifesciences Corporation | $503.19 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $481.81 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $441.53 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $441.53 | 2019-2025 | Jardiance |
| Pfizer INC. | $391.49 | 2019-2025 | |
| Atricure, INC. | $352.45 | 2021-2024 | |
| Novo Nordisk INC | $350.16 | 2021-2025 | Ozempic, Wegovy |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $334.03 | 2019-2022 | |
| Medtronic Vascular, INC. | $276.53 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $255.77 | 2022-2024 | Assure Wcd |
| Esperion Therapeutics, INC. | $245.18 | 2021-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $228.18 | 2021-2024 | Verquvo |
| Chiesi USA, INC. | $191.23 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $164.63 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Medtronic, INC. | $163.62 | 2022-2025 | Linq II, Endurant Iis |
| Globus Medical, INC. | $152.37 | 2025 | Senza |
| Acacia Pharma INC | $114.05 | 2021-2022 | |
| Vifor Pharma, INC. | $106.72 | 2025 | Veltassa |
| Lundbeck LLC | $99.68 | 2019-2021 | |
| Bardy Diagnostics, INC. | $90.00 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $89.22 | 2024 | Arcalyst |
| Angiodynamics, INC. | $82.55 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Heartflow, INC. | $79.87 | 2023 | Ffrct |
| Cmp Pharma, INC. | $72.11 | 2023-2025 | Atorvaliq, Liqrev, Tadliq |
| Inspire Medical Systems, INC. | $70.98 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $67.38 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $64.94 | 2019-2023 | |
| Daiichi Sankyo INC. | $63.99 | 2022-2023 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $62.67 | 2019-2021 | |
| Astellas Pharma US INC | $59.34 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $58.71 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $55.95 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.98 | 2022-2025 | |
| Cvrx, INC. | $51.99 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $43.02 | 2022-2023 | Arcalyst |
| Philips North America LLC | $40.08 | 2022 | |
| Biosense Webster, INC. | $37.86 | 2023 | Carto 3 |
| Medicomp INC | $37.55 | 2019 | |
| Tactile Systems Technology INC | $36.84 | 2024 | Entre Plus, Flexitouch Plus |
| Organogenesis INC. | $33.34 | 2021 | |
| Glaxosmithkline, LLC. | $32.72 | 2019-2025 | Shingrix, Arexvy |
| Amryt Pharma Holdings LTD | $27.07 | 2023 | Juxtapid |
| Recor Medical INC | $24.56 | 2024 | Paradise Renal Denervation System |
| Abbvie INC. | $17.97 | 2021 | |
| Advanced Oxygen Therapy INC. | $15.65 | 2024 | Topical Oxygen Chamber For Extremities |
| Biohaven Pharmaceutical Holding Company LTD. | $14.96 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $12.20 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.